Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigational Varicella Vaccine vs Varivax in Healthy Children
NCT06806137Phase 3Recruiting
- Sponsor
- GSK
- Start
- May 2025
- Primary completion
- Dec 2026
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 2
01
Overview
A Phase 3 trial of Investigational varicella vaccine in chickenpox, sponsored by GSK. Started May 2025; status: recruiting.
02
Drugs
Investigational varicella vaccine
03
Conditions
chickenpox
Beyond the preview
Go deeper on NCT06806137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06806137.